Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy

L Adhikary1, F Chow1,2, D J Nikolic-Paterson1,2

  • 1Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia.

Diabetologia
|July 3, 2004
PubMed
Abstract

Insights

Increased p38 mitogen-activated protein kinase (MAPK) signaling is linked to diabetic nephropathy development. This pathway activation, particularly in kidney cells, correlates with fibrosis, suggesting a pathological role in diabetes complications.

Area of Science:

  • Cellular signaling pathways in renal pathology
  • Molecular mechanisms of diabetic kidney disease

Background:

  • Diabetic nephropathy involves inflammation and fibrosis.
  • The p38 MAPK pathway regulates these processes.
  • High glucose and advanced glycation end-products activate p38 MAPK in renal cells.

Purpose of the Study:

  • To investigate the association between p38 MAPK signaling and diabetic nephropathy.
  • To examine p38 MAPK activation in human diabetic kidney disease.
  • To assess the role of p38 MAPK in experimental models of diabetes.

Main Methods:

  • Immunostaining of human kidney biopsies (normal vs. Type 2 diabetic nephropathy).
  • Western blotting and immunostaining in mouse models of Type 1 (streptozotocin-induced) and Type 2 (db/db) diabetes.
  • Assessment of p38 MAPK activation over time in diabetic mice.

Main Results:

  • Phosphorylated p38 MAPK was found in human diabetic nephropathy, increased in interstitial macrophages and myofibroblasts.
  • Similar p38 activation patterns were observed in both mouse models.
  • Kidney p38 levels increased in diabetic mice, correlating with hyperglycemia, albuminuria, and interstitial fibrosis.

Conclusions:

  • Elevated p38 MAPK signaling is characteristic of human and experimental diabetic nephropathy.
  • Studies in mice suggest p38 phosphorylation plays a pathological role.
  • The p38 pathway is particularly implicated in the development of interstitial fibrosis in diabetic kidneys.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...